“…Consequently, it is far more practical to perform a thorough scan at around 16 weeks to look for soft signs other than AHNB, and then to prioritize the woman for intrusive testing. Numerous studies have proposed a similar methodology (Benacerraf et al, 2019; Desai et al, 2019; Zhang et al, 2021) Adhering to this strategy in low‐resource situations will lower costs and the number of invasive treatments performed. However, when doing invasive testing, the sample should be sent for a more detailed analysis of the genomic structure of the fetus, like the microarray, over the conventional karyotype, as has been outlined in several studies (Fantasia et al, 2020; Gu et al, 2019; Shi et al, 2022; Zhang et al, 2021).…”